AstraZeneca, a biopharmaceutical company, has completed the purchase of a US-based biotechnology company, Ardea Biosciences. Upon completion of the merger, approved by Ardea's stockholders, each outstanding share of Ardea common stock has ...
Tags: purchase, AstraZeneca, Ardea Biosciences, biopharmaceutical
AstraZeneca and Ardea Biosciences have entered into a definitive merger agreement, under which AstraZeneca will acquire Ardea for $1.26bn including a product lesinurad in Phase III development for gout. As per the agreement, AstraZeneca ...
Tags: AstraZeneca, Ardea, merger agreement, gout